Jiangsu Run'an Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd., a modern high-tech pharmaceutical company specializing in the R&D, production and sales of fertility regulation drugs and variety APIs. The project started construction in November 2018, covering an area of 59 mu, with a total investment of 160 million yuan and a total building area of about 25000 square meters.
Our products are Active pharmaceutical Ingredient (API), Pharmaceutical Intermediate, Tetrazole, Iminazole, Pyridine, Heterocyclics.
Main Active pharmaceutical ingredient (API) products: Gemcitabine hydrochloride, Celecoxib, bromhexine HCl, Iguratimod, Apremilast, Tofactinib Citrate, Crisaborole, Urapidil Hydrochloride, Sugammadex sodium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium bromide, Finerenone, Sodium risedronate, etc.
Main Pharmaceutical intermediate products: Gemcitabine HCl T9, Gemcitabine HCl T8, Gemcitabine HCl T6, Gemcitabine HCl T3, etc.
We aim to become a world-class developer and manufacturer of reproductive products through constant improvement and innovation in technologies, and offer remarkable business opportunities to our partner companies worldwide. Our commitment to outstanding customer service has allowed us to forge solid relationships with our partners all over the world.
Molecular formula: C19H14F2O6
Molecular weight: 376.31
CAS#122111-01-7 is for intermediate for Gemcitabine Hydrochloride.
Molecular formula: C19H14F2O6
Molecular weight: 376.31
CAS NO.122111-01-7 is for intermediate for Gemcitabine Hydrochloride.
Molecular formula: C19H14F2O6
Molecular weight: 376.31
CAS 122111-01-7 is for intermediate for Gemcitabine Hydrochloride.
Molecular formula: C19H14F2O6
Molecular weight: 376.31
122111-01-7 is for intermediate for Gemcitabine Hydrochloride.
Molecular formula: C19H14F2O6
Molecular weight: 376.31
Gemcitabine T6 is for intermediate for Gemcitabine Hydrochloride.